“Tough Cases” Doug Wolf and Gil Y. Melmed Advances in IBD Hollywood, FL December, 2013.

Slides:



Advertisements
Similar presentations
Immunomodulators and Biologics Maria T. Abreu, MD University of Miami Miller School of Medicine Miami, Florida.
Advertisements

GI tract infections in IBD: Detection and treatment of Clostridium difficile, CMV and enteric pathogens: Case studies David G. Binion, MD Bruce E. Sands,
Lower Gastrointestinal Bleeding
Treating the Challenging Inpatient with Complicated IBD: Case Studies
Colitis in the Very Young
Management of Inflammatory bowel disease 8/12/10.
NYU Medical Grand Rounds Clinical Vignette Rennie Rhee MD, PGY-2 January 13, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
HPI A 25 year old Caucasian male presents to your clinic with two month history of crampy abdominal pain and diarrhea. What else would you like to know?
A patient with severe Crohn's disease, an ileal stricture and proximal dilation on CTE should have medical therapy first Uma Mahadevan MD Professor of.
Challenges in Surgery for Severe, Refractory Ulcerative Colitis: Case Studies Phillip R. Fleshner,M.D. Shierley,Jesslyne,and Emmeline Widjaja Chair in.
IMAGE CHALLENGE. A 51-year-old woman with a history of hypertension and chronic constipation presented with abdominal pain of 2 weeks' duration. The.
Thiopurines still have a role in the management of pediatric IBD Athos Bousvaros MD, MPH Associate Director, IBD program Boston Children’s Hospital.
What do we do when the patient loses their response to an anti-TNF: Minor tweaks or major treatment changes? Robert N. Baldassano, MD Colman Professor.
Treating the Outpatient with Severe IBD: Case Discussions William Tremaine, MD Corey A. Siegel, MD.
End points in IBD treatment Mucosal healing Vs Symptom relief Jose Francis Lakeshore Hospital Kochi.
Treating the outpatient with severe IBD: Case studies Daniel H. Present, MD, MACG Clinical Professor of Medicine The Mount Sinai School of Medicine Russell.
Ulcerative Colitis.
The Patient With Pyoderma Gangrenosum Maria T. Abreu, MD Chief, Division of Gastroenterology University of Miami Miller School of Medicine Miami, Florida.
Ghassan Wahbeh MD Associate Professor, Director IBD Program Seattle Children’s Hospital University of Washington.
When can we use combination therapy for our pediatric IBD patients? Athos Bousvaros MD, MPH Advances in IBD Dec 2014.
Progress in Diagnosing and Treating Clostridium difficile in IBD patients Alan C. Moss MD, FEBG, FACG, AGAF Associate Professor of Medicine Director of.
Inflammatory Bowel Disease
Crohn’s disease - A Review of Symptoms and Treatment
Inflammatory Bowel Disease Treatment. Epidemiology Clinical Laboratory Imaging Pathology Response to treatment IBD.
Inflammatory Bowel Diseases Dr. Nematollah Ahangar Assistant Prof. of Pharmacology.
Case A 25-year-old woman A 4-m history of abdominal pain in the left lower quadrant and bloody diarrhea.
Case Study Advances 2014 Betty White C-NP
(Date of presentation) (Name of presenter) UK IBD audit Biological therapies audit 2014 Comparison of (Your site name) results against the national results.
Therapeutic algorithms for Crohn’s disease: Where are we in 2012?
شاهین زارع.
Is the capsule a guiding star ? Dr. Niv Eva Department of Gastroenterology Tel-Aviv Sourasky Medical Center.
By: Leon Richardson Period 2
Raneen Omary. Contents Definition Pathogenesis Epidemiology Acute Radiation Enteritis Chronic Radiation Enteritis Risk Factors Diagnosis DD Medical Management.
CASE HISTORY #1 AIBD Breakout Session Douglas C. Wolf, M.D.
A Case of Crohn’s Disease Rich Rames, M3 May/June 2013 Dr. Joy Sclamberg, Dr. James Cameron, Dr. Aditi Gulabani.
NYU Medical Grand Rounds Clinical Vignette Verity Schaye MD, PGY-2 February 3, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Definitions UC Inflammation confined to mucosa Inflammation confined to mucosa Starting in rectum Starting in rectum May involve entire colon May involve.
Dr. Gholam Reza Khatami Ulcerative colitis is a chronic gastrointestinal disease Given modern treatment, medical management is not curative.
Fecal calprotectin DR Amin Eftekhari.
Case Presentation 34 y/o male34 y/o male 5 years Crohn’s disease of ileum and Rt. colon5 years Crohn’s disease of ileum and Rt. colon 10 days – Fever,
IBD Patient Update Case Vignettes 12 November 2011.
Mimics of IBD Sunanda Kane MD MSPH Mayo Clinic Rochester.
The only end-points of therapy that matter are mucosal healing, normal blood work, and negative radiologic studies. Robert N. Baldassano, MD Colman Family.
NYU Medical Grand Rounds Clinical Vignette Andy Levy, MD PGY-2 March 26, 2013 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
PANEL DISCUSSION SURGERY FOR CROHNS DISEASE. AD 24 female Crohns disease since 2001 on penatasa, budesonide, prednisolone needle phobia resolved by psychologist.
Crohn Disease (Regional Enteritis)
It's Time A 63-year-old woman was admitted because of severe abdominal pain, fatigue and bloody diarrhea.
IBD Cases Stephen B. Hanauer, MD Professor of Medicine Feinberg School of Medicine Medical Director, Digestive Health Center.
You Can Never Stop a Biologic
Natalizumab- Unmet Need in the Management of Crohn’s Disease Doug Wolf, M.D. Atlanta Gastroenterology Associates July 31, 2007.
IBD Treatment: The Basics
DISEASES OF SMALL INTESTINE. PLAN CROHN’S DISEASE (CD) Etiology and Etiology and Epidemiology of CROHN’S DISEASE Pathology of CROHN’S DISEASE Pathology.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
Inflammatory Bowel Disease Crohn’s Disease And Ulcerative Colitis.
Kim Eastman RN,MSN, CNS. INFLAMMATORY BOWEL DISEASE  OVERVIEW  IMMUNOLOGIC DISEASE THAT RESULTS IN INTESTINAL INFLAMMATION  ULCERATIVE COLITIS  CROHN’S.
Xavier Roblin, MD, PhD 1, M. Rinaudo, MD 2, E. Del Tedesco, MD 1, J.M. Phelip, MD, PhD 1, C. Genin, MD, PhD 2, L. Peyrin-Biroulet, MD, PhD 3 and S. Paul,
بسم الله الرحمن الرحيم. management protocol of IBD.
Chief Complaint FOBT positive Present Illness 61/M, 2011 년 본원 신경과에서 Dysarthria 로 언어장애 4 급 판정이외에 다른 특이병력 없는 자로, 2015 년 7 월 산업의학과에서 시행한 검진상 분변잠혈반응 검사 양성이.
MIGUEL REGUEIRO, WOLFGANG SCHRAUT, LEONARD BAIDOO, KEVIN E. KIP, ANTONIA R. SEPULVEDA, MARILYN PESCI, JANET HARRISON, SCOTT E. PLEVY GASTROENTEROLOGY 2009;136:441–450.
Improving outcome of Inflammatory Bowel Disease in children Dinesh Pashankar, MD Pediatric Gastroenterologist Director- Pediatric IBD program Yale University.
Miliary TB.
Rahul A. Nathwani, MD, FACG
CASE DISCUSSION: Crohn's disease patient with bad perianal disease- are new therapies any help? Alana Wichmann, APN, MSN, FNP, Advanced Practice Nurse,
Crohn´s disease Domina Petric, MD.
מחלות מעי דלקתיות והטיפול בהן
Raymond Cross, MD, MS, AGAF Associate Professor of Medicine
Article by: Zubin Grover , Richard Muir, and Peter lewindon
Lecture 12 Gastrointestinal Disorders Inflammatory Bowel Disease
Prevention of Postoperative Recurrence in Crohn's Disease
Crohn’s Disease Biologic Pathway
Presentation transcript:

“Tough Cases” Doug Wolf and Gil Y. Melmed Advances in IBD Hollywood, FL December, 2013

71 yr retired virologist Diagnosed Crohn’s Disease at age 24 –Initial presentation in 1966 –Diarrhea and perianal abscess –Over next 30 years, 5 ileal resections and many I & D procedures for perianal abscesses – multiple courses prednisone On prednisone since 1966 – addisonian – 6-MP, metronidazole Not effective. Now what?

In 1997, age 55-Diverting ileostomy due to refractory fistulizing CD 5/2000 -Colonoscopy – Perianal fistulas, 40 cm of ileal Crohn’s disease, no colonic disease. 1/01 - started infliximab 5 mg/kg 0, 2, 6 and q8w 5/01 - Fistula healed after 5 th infliximab dose 6/01 - Ileostomy reversed 71 yr retired virologist

8/13/01 – brought to the emergency room by ambulance –Hypotensive, hands cool, confused –Hypoxemic, tachycardic –CXR – widened mediastinum –ECHO – large pericardial effusion 71 yr retired virologist

What is the cause? –Heart failure from infliximab –Pneumonia from infliximab –Neoplasm from infliximab –Tuberculosis

Timing of TB with Infliximab – typically occurs between 3-5 th dose

Diagnosis: M. tuberculosis Treatment: –Rifampin, INH x 6 months –PZA, ethambutol x 2 months IFX held during TB therapy Symptoms (diarrhea, fistula) recur 71 yr retired virologist

Now What? Can he safely receive an anti-TNF agent ever again?

Decision made to resume IFX after 8m –Any concern for immunogenicity? –Reinduction? 71 yr retired virologist

Infliximab resumed: 0,2,6 re-induction. (low dose steroid coverage) –Initial response but gradual loss of response –Dose escalation –symptom recurrence –No TB recurrence! 71 yr retired virologist

Which treatment would you try next? –Start 6-MP –Adalimumab (ADA) (off-label) –ADA/6-MP combination –ADA/methotrexate combination Now What?

Continues low dose prednisone (5mg/d) Treated with ADA 160/80 induction and 40 mg q.o.w./6-MP. –Developed rash. –6-MP discontinued –ADA level checked – 3……. Switched to ADA/MTX –Excellent response 71 yr retired virologist

2006 – Goes to Italy for 2 weeks Returns home with 3 days of feeling ill –Fever, SOB, weak –CXR and CT- left upper lobe consolidation 71 yr retired virologist

Differential diagnosis? a) Recurrent tuberculosis b) Pulmonary malignancy c) Methotrexate toxicity d) Legionella pneumophila e) Bacterial pneumonia 71 yr retired virologist

Bronchoscopy – negative Urinary Legionella antigen positive. 71 yr retired virologist

Adalimumab and methotrexate held Treated for Legionella pneumophia……. Levofloxacin 750 mg a day for 21 days Adalimumab and methotrexate resumed 1 week after completing Levofloxacin 71 yr retired virologist

2y later- new painful, vesicular rash on left flank Medications: –Adalimumab –methotrexate 15 mg/wk –prednisone 9 mg/day What is this rash? 71 yr retired virologist

What to do about IBD medications? –Valtrex for Shingles –Hold adalimumab and methotrexate? How long? 71 yr retired virologist

Case 2

32 y Lawyer 5y ago: diarrhea, pain/blood with defecation –CRS: “proctitis”, “elephant skin tags” “fissure”, “see GI” PMHx: ‘Back surgery’ Meds: Norco (back pain) FHx: No IBD or CRC Exam: Mild LLQ tenderness WBC 11.0, Hgb 11.9, alb 3.5, ESR 14, CRP 1.26

32 y Lawyer T Ileum Tr Colon R Colon L Colon

Initiate treatment, or does he need further dx tests? –Serology? –Any need for imaging? –EGD? Capsule Endoscopy?

32 y Lawyer Serology – –pANCA=45 (<15) –ASCA IgA = 17.5 (<20) –ASCA IgG = undetectable –OMPC 18.1 (<16.5) –CBir = 42 –“UC Predicted” CT Enterography –“thickening of wall of L colon” –“thickening of multiple mid small bowel loops with enhancement” Rheumatologist –“spondyloarthritis”

What treatment to start with?

32 y Lawyer Treated with –2 weeks metronidazole –Pentasa 8/day and Rowasa enemas –adalimumab monotherapy At 6 weeks, no change in symptoms At 8 weeks, FS showed no change in mucosal inflammation

Now what??

32 y Lawyer Adalimumab discontinued at 12 weeks due to ‘primary nonresponse’ Started Prednisone 40mg, 6-MP 1.5mg/kg Immediate improvement 4 months later, unable to wean below 15mg prednisone despite therapeutic 6MP levels

Now what???

32 y Lawyer Patience with 6mp! –2 months later, still steroid-dependent Added infliximab Transient response after first 2 doses –Increased to 10mg q6w –Poor response

32 y Lawyer Admitted for severe disease Colonoscopy –Deep ulcers, path with very active CMV –Polyp at 60cm (inflamed area), “tubular adenoma” –Referred for surgery –Dramatic clinical improvement with CMV treatment, refusing surgery –Infliximab drug levels low at 4w

32 y Lawyer Discharged on ganciclovir slow taper Refused infliximab Went on carbohydrate-restricted diet off all meds 6m later in clinical and endoscopic remission 6m later (June, 2013) started to have symptoms again…

Now what???

32y Lawyer Started prednisone and off-label ustekinumab July 2013 Weaned off prednisone Sept 2013 Continues to do well on 90mg q8w sq ustekinumab…